166 related articles for article (PubMed ID: 34567803)
61. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
[TBL] [Abstract][Full Text] [Related]
62. Successful management of small cell neuroendocrine carcinoma of the ureter with neoadjuvant chemotherapy and adjuvant chemoradiation: case report and literature review.
Farooq M; Daniel S; Joel A; Thampi John N
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34404642
[TBL] [Abstract][Full Text] [Related]
63. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
[TBL] [Abstract][Full Text] [Related]
64. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
65. [Neuroendocrine tumors: analysis of 252 cases].
Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305
[TBL] [Abstract][Full Text] [Related]
66. Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
Boustani J; Achkar S; Bertaut A; Genestie C; Gouy S; Pautier P; Morice P; Haie-Meder C; Chargari C
Cancer Radiother; 2021 May; 25(3):207-212. PubMed ID: 33408051
[TBL] [Abstract][Full Text] [Related]
67. [A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11+CDDP chemotherapy after non-curative surgery].
Tanimoto H; Hamasaki A; Akimoto Y; Honda H; Takao Y; Okamoto K; Teramoto M; Teramoto H; Kaneko M; Oshita T
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1439-41. PubMed ID: 22996787
[TBL] [Abstract][Full Text] [Related]
68. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
[TBL] [Abstract][Full Text] [Related]
69. Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Honma Y; Nagashima K; Hirano H; Shoji H; Iwasa S; Takashima A; Okita N; Kato K; Boku N; Murakami N; Inaba K; Ito Y; Itami J; Kanamori J; Oguma J; Daiko H
Cancer Med; 2020 Jan; 9(2):595-604. PubMed ID: 31794158
[TBL] [Abstract][Full Text] [Related]
70. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
71. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
72. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
73. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
[TBL] [Abstract][Full Text] [Related]
74. Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer.
Pan B; Wan T; Jiang Y; Zheng X; Liu P; Xiang H; Zheng M
BMC Cancer; 2022 Jun; 22(1):655. PubMed ID: 35698184
[TBL] [Abstract][Full Text] [Related]
75. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery.
Kumar JV; Doval DC; Rao R; Rawal S
Int J Gynecol Cancer; 2009 Apr; 19(3):417-22. PubMed ID: 19407570
[TBL] [Abstract][Full Text] [Related]
76. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
77. Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.
Sroussi M; Elaidi R; Fléchon A; Lorcet M; Borchiellini D; Tardy MP; Gravis G; Guérin M; Laguerre B; Estrade F; Delva R; Barthélémy P; Loriot Y; Lavaud P; Lebret T; Neuzillet Y; Penel N; Houede N; Pouessel D; Rousseau B; Mussat E; Gross-Goupil M; Culine S; Gauthier H; Gobert A; Roupret M; Huillard O; Tartas S; Radulescu C; Allory Y; Oudard S
Clin Genitourin Cancer; 2020 Aug; 18(4):295-303.e3. PubMed ID: 31882335
[TBL] [Abstract][Full Text] [Related]
78. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
[TBL] [Abstract][Full Text] [Related]
79. Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
Okazawa-Sakai M; Yokoyama T; Fujimoto E; Okame S; Shiroyama Y; Yokoyama T; Takehara K
Int J Clin Oncol; 2018 Aug; 23(4):715-725. PubMed ID: 29446043
[TBL] [Abstract][Full Text] [Related]
80. Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma.
Yu L; Suye S; Huang R; Liang Q; Fu C
J Clin Pathol; 2021 Dec; 74(12):787-795. PubMed ID: 33060116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
